Point-of-Care Coagulation (POCC) Testing Devices Market Size, Share & Industry Analysis, By Device Type (Anticoagulation Monitoring Devices {Prothrombin Time/International Normalized Ratio (PT/INR) Testing Devices, Activated Clotting Time (ACT), and Activated Partial Thromboplastin Time (aPPT)}, Platelet Function Monitoring Devices, Viscoelastic Coagulation Monitoring Devices {Thromboelastography (TEG) and Rotational Thromboelastometry (ROTEM)}, and Others), By End User (Hospitals & Clinics, Homecare, and Others), and Regional Forecast, 2024-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI101235

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2032
Base Year	2023
Estimated Year	2024
Forecast Period	2024-2032
Historical Period	2019-2022
Growth rate	CAGR of 7.0% from 2024-2032
Unit	Value (USD billion)
Segmentation	By Device Type Anticoagulation Monitoring Devices Prothrombin Time/International Normalized Ratio (PT/INR) Testing Devices Activated Clotting Time (ACT) Activated Partial Thromboplastin Time (aPTT) Platelet Function Monitoring Devices Viscoelastic Coagulation Monitoring Devices Thromboelastography (TEG) Rotational Thromboelastometry (ROTEM) Others
	By End User Hospitals & Clinics Homecare Others
	By Geography North America (By Device Type, By End User, By Country) U.S. Canada Europe (By Device Type, By End User, By Country/Sub-region) U.K. Germany France Italy Spain Scandinavia Rest of Europe Asia Pacific (By Device Type, By End User, By Country/Sub-region) Japan China India Australia Southeast Asia Rest of the Asia Pacific Latin America (By Device Type, By End User, By Country/Sub-region) Brazil Mexico Rest of Latin America Middle East & Africa (By Device Type, By End User, By Country/Sub-region) GCC South Africa Rest of the Middle East & Africa